|
[1] CARREAU A,EL HAFNY-RAHBI B,MATEJUK A,et al. Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia[J]. J Cell Mol Med,2011,15(6):1239-1253.
|
|
[2] RAPPAPORT AM. The structural and functional unit in the human liver(liver acinus)[J]. Anat Rec,1958,130(4):673-689.
|
|
[3] JUNGERMANN K,KIETZMANN T. Oxygen:Modulator of metabolic zonation and disease of the liver[J]. Hepatology,2000,31(2):255-260.
|
|
[4] ROSMORDUC O,HOUSSET C. Hypoxia:A link between fibrogenesis,angiogenesis,and carcinogenesis in liver disease[J]. Semin Liver Dis,2010,30(3):258-270.
|
|
[5] BROUGHAN TA,NAUKAM R,TAN C,et al. Effects of hepatic zonal oxygen levels on hepatocyte stress responses[J]. J Surg Res,2008,145(1):150-160.
|
|
[6] NATH B,SZABO G. Hypoxia and hypoxia inducible factors:Diverse roles in liver diseases[J]. Hepatology,2012,55(2):622-633.
|
|
[7] SNODGRASS RG,BOβM,ZEZINA E,et al. Hypoxia potentiates palmitate-induced pro-inflammatory activation of primary human macrophages[J]. J Biol Chem,2016,291(1):413-424.
|
|
[8] WILSON GK,TENNANT DA,MCKEATING JA. Hypoxia inducible factors in liver disease and hepatocellular carcinoma:Current understanding and future directions[J]. J Hepatol,2014,61(6):1397-1406.
|
|
[9] QU A,TAYLOR M,XUE X,et al. Hypoxia-inducible transcription factor 2αpromotes steatohepatitis through augmenting lipid accumulation,inflammation,and fibrosis[J]. Hepatology,2011,54(2):472-483.
|
|
[10] LEFERE S,van STEENKISTE C,VERHELST X,et al. Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease[J]. Cell Mol Life Sci,2016,73(18):3419-3431.
|
|
[11] XIANG DM,SUN W,NING BF,et al. The HLF/IL-6/STAT3feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis[J]. Gut,2018,67(9):1704-1715.
|
|
[12] FRIEDMAN SL. Mechanisms of hepatic fibrogenesis[J]. Gastroenterology,2008,134(6):1655-1669.
|
|
[13] COPPLE BL,BAI S,BURGOON LD,et al. Hypoxia-inducible factor-1αregulates the expression of genes in hypoxic hepatic stellate cells important for collagen deposition and angiogenesis[J]. Liver Int,2011,31(2):230-244.
|
|
[14] ANKOMA-SEY V,WANG Y,DAI Z. Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells[J]. Hepatology,2000,31(1):141-148.
|
|
[15] NOVO E,CANNITO S,ZAMARA E,et al. Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells[J]. Am J Pathol,2007,170(6):1942-1953.
|
|
[16] TAURA K,DE MINICIS S,SEKI E,et al. Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis[J]. Gastroenterology,2008,135(5):1729-1738.
|
|
[17] TESTONI B,LEVRERO M,ZOULIM F. Chal enges to a cure for HBV infection[J]. Semin Liver Dis,2017,37(3):231-242.
|
|
[18] ONORI P,MORINI S,FRANCHITTO A,et al. Hepatic microvascular features in experimental cirrhosis:A structural and morphometrical study in CCl4-treated rats[J]. J Hepatol,2000,33(4):555-563.
|
|
[19] HOUSSET C,ROCKEY DC,BISSELL DM. Endothelin receptors in rat liver:Lipocytes as a contractile target for endothelin 1[J].Proc Natl Acad Sci U S A,1993,90(20):9266-9270.
|
|
[20] ROCKEY DC,FOUASSIER L,CHUNG JJ,et al. Cellular localization of endothelin-1 and increased production in liver injury in the rat:Potential for autocrine and paracrine effects on stellate cells[J]. Hepatology,1998,27(2):472-480.
|
|
[21] MCKEOWN SR. Defining normoxia,physoxia and hypoxia in tumours-implications for treatment response[J]. Br J Radiol,2014,87(1035):20130676.
|
|
[22] LUO D,WANG Z,WU J,et al. The role of hypoxia inducible factor-1 in hepatocellular carcinoma[J]. Biomed Res Int,2014,2014:409272.
|
|
[23] JU C,COLGAN SP,ELTZSCHIG HK. Hypoxia-inducible factors as molecular targets for liver diseases[J]. J Mol Med(Berl),2016,94(6):613-627.
|
|
[24] YANG W,LU Z. Nuclear PKM2 regulates the Warburg effect[J]. Cell Cycle,2013,12(19):3154-3158.
|
|
[25] ZHANG TB,ZHAO Y,TONG ZX,et al. Inhibition of glucosetransporter 1(GLUT-1)expression reversed Warburg effect in gastric cancer cell MKN45[J]. Int J Clin Exp Med,2015,8(2):2423-2428.
|
|
[26] PUGH CW,RATCLIFFE PJ. Regulation of angiogenesis by hypoxia:Role of the HIF system[J]. Nat Med,2003,9(6):677-684.
|
|
[27] WANG GL,JIANG BH,RUE EA,et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2tension[J]. Proc Natl Acad Sci U S A,1995,92(12):5510-5514.
|
|
[28] LOENARZ C,COLEMAN ML,BOLEININGER A,et al. The hypoxia-inducible transcription factor pathway regulates oxygen sensing in the simplest animal,Trichoplax adhaerens[J].EMBO Rep,2011,12(1):63-70.
|
|
[29] HAHNE M,SCHUMANN P,MURSELL M,et al. Unraveling the role of hypoxia-inducible factor(HIF)-1αand HIF-2αin the adaption process of human microvascular endothelial cells(HMEC-1)to hypoxia:Redundant HIF-dependent regulation of macrophage migration inhibitory factor[J]. Microvasc Res,2018,116:34-44.
|
|
[30] GODA N,KANAI M. Hypoxia-inducible factors and their roles in energy metabolism[J]. Int J Hematol,2012,95(5):457-463.
|
|
[31] BERRA E,BENIZRI E,GINOUVS A,et al. HIF prolylhydroxylase 2 is the key oxygen sensor setting low steadystate levels of HIF-1alpha in normoxia[J]. EMBO J,2003,22(16):4082-4090.
|
|
[32] MARXSEN JH,STENGEL P,DOEGE K,et al. Hypoxia-inducible factor-1(HIF-1)promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases[J]. Biochem J,2004,381(Pt 3):761-767.
|
|
[33] LANDO D,PEET DJ,WHELAN DA,et al. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch[J].Science,2002,295(5556):858-861.
|
|
[34] DAYAN F,ROUX D,BRAHIMI-HORN MC,et al. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha[J].Cancer Res,2006,66(7):3688-3698.
|
|
[35] ROTH KJ,COPPLE BL. Role of hypoxia-inducible factors in the development of liver fibrosis[J]. Cell Mol Gastroenterol Hepatol,2015,1(6):589-597.
|
|
[36] LUO W,HU H,CHANG R,et al. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1[J]. Cell,2011,145(5):732-744.
|
|
[37] JIAO M,NAN KJ. Activation of PI3 kinase/Akt/HIF-1αpathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma[J]. Int J Oncol,2012,40(2):461-468.
|
|
[38] DEKANTY A,LAVISTA-LLANOS S,IRISARRI M,et al. The insulin-PI3K/TOR pathway induces a HIF-dependent transcriptional response in Drosophila by promoting nuclear localization of HIF-alpha/Sima[J]. J Cell Sci,2005,118(Pt 23):5431-5441.
|
|
[39] AGANI F,JIANG BH. Oxygen-independent regulation of HIF-1:Novel involvement of PI3K/AKT/m TOR pathway in cancer[J].Curr Cancer Drug Targets,2013,13(3):245-251.
|
|
[40] MORELLO E,SUTTI S,FOGLIA B,et al. Hypoxia-inducible factor 2αdrives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine-rich glycoprotein[J].Hepatology,2018,67(6):2196-2214.
|
|
[41] JIN H,LIAN N,BIAN M,et al. Oroxylin A prevents alcohol-induced hepatic steatosis through inhibition of hypoxia inducible factor 1alpha[J]. Chem Biol Interact,2018,285:14-20.
|
|
[42] ZHANG J,ZHANG Q,LOU Y,et al. Hypoxia-inducible factor-1α/interleukin-1βsignaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment[J]. Hepatology,2018,67(5):1872-1889.
|
|
[43] FRIEDMAN SL. Liver fibrosis-from bench to bedside[J]. J Hepatol,2003,38(Suppl 1):s38-s53.
|
|
[44] MOON JO,WELCH TP,GONZALEZ FJ,et al. Reduced liver fibrosis in hypoxia-inducible factor-1alpha-deficient mice[J]. Am J Physiol Gastrointest Liver Physiol,2009,296(3):g582-g592.
|
|
[45] ZHOU D,ZHANG LT,LI JF,et al. Mechanism of action of hypoxia-inducible factor 1αin the development and progression of liver fibrosis[J]. J Clin Hepatol,2019,35(7):1604-1607.(in Chinese)周丹，张立婷，李俊峰，等．缺氧诱导因子1α在肝纤维化发生发展中的作用机制[J]．临床肝胆病杂志，2019,35(7):1604-1607.
|
|
[46] NOVO E,POVERO D,BUSLETTA C,et al. The biphasic nature of hypoxia-induced directional migration of activated human hepatic stellate cells[J]. J Pathol,2012,226(4):588-597.
|
|
[47] LIU X,HUANG K,NIU Z,et al. Protective effect of isochlorogenic acid B on liver fibrosis in non-alcoholic steatohepatitis of mice[J]. Basic Clin Pharmacol Toxicol,2019,124(2):144-153.
|
|
[48] YAO DF,JIANG H,YAO M,et al. Quantitative analysis of hepatic hypoxia-inducible factor-1alpha and its abnormal gene expression during the formation of hepatocellular carcinoma[J]. Hepatobiliary Pancreat Dis Int,2009,8(4):407-413.
|
|
[49] ZHANG L,HUANG G,LI X,et al. Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxiainducible factor-1αin hepatocellular carcinoma[J]. BMC Cancer,2013,13:108.
|
|
[50] WANG M,ZHAO X,ZHU D,et al. HIF-1αpromoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment[J].J Exp Clin Cancer Res,2017,36(1):60.
|
|
[51] YANG SC,ZHANG L,LIU LP,et al. Effect of hypoxia-inducible factor 2αon chemoresistance of hepatocel-lular carcinoma[J]. Chin J Clin Pharmacol Ther,2019,24(6):630-636.(in Chinese)杨书才，张莉，刘利平，等．缺氧诱导因子2α对肝细胞癌化疗耐药性的影响[J]．中国临床药理学与治疗学，2019,24(6):630-636.
|
|
[52] MNDEZ-BLANCO C,FONDEVILA F,GARCA-PALOMO A,et al. Sorafenib resistance in hepatocarcinoma:Role of hypoxia-inducible factors[J]. Exp Mol Med,2018,50(10):1-9.
|
|
[53] WU Q,ZHOU W,YIN S,et al. Blocking triggering receptor expressed on myeloid cells-1-positive tumor-associated macrophages induced by hypoxia reverses immunosuppression and anti-programmed cell death ligand 1 resistance in liver cancer[J]. Hepatology,2019,70(1):198-214.
|
DownLoad: